YD Bio Limited Ordinary Shares
Status: Publicly traded
Direct answer
YD Bio Limited Ordinary Shares is publicly traded on NASDAQ under the ticker YDES.
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Can you invest in YD Bio Limited Ordinary Shares?
Yes. YD Bio Limited Ordinary Shares is publicly traded on NASDAQ under the ticker YDES.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for YD Bio Limited Ordinary Shares
Detailed equity research is provided by MarketSnap.